These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18075509)

  • 1. Ethical problems with bioidentical hormone therapy.
    Rosenthal MS
    Int J Impot Res; 2008; 20(1):45-52. PubMed ID: 18075509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study.
    Ruiz AD; Daniels KR; Barner JC; Carson JJ; Frei CR
    BMC Womens Health; 2011 Jun; 11():27. PubMed ID: 21651797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks.
    Moskowitz D
    Altern Med Rev; 2006 Sep; 11(3):208-23. PubMed ID: 17217322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An expert offers advice on the use of unregulated, custom-compounded hormones.
    Pinkerton JV
    Geriatrics; 2008 Sep; 63(9):1 p following 20. PubMed ID: 18798364
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioidentical hormone therapy: a panacea that lacks supportive evidence.
    Boothby LA; Doering PL
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):400-7. PubMed ID: 18660693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wiley Protocol: an analysis of ethical issues.
    Rosenthal MS
    Menopause; 2008; 15(5):1014-22. PubMed ID: 18551081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informing patients of the risks and benefits of hormone replacement therapy: nephrologists' ethical obligation.
    Noland LR
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):387-90. PubMed ID: 15492976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioidentical hormone therapy. An overview of benefits and prescribing guidance.
    Collins D
    Adv Nurse Pract; 2008 May; 16(5):41-4, 46, 68. PubMed ID: 19999070
    [No Abstract]   [Full Text] [Related]  

  • 11. Prepublication review of medical ethics research: cause for concern.
    Landy DC; Coverdale JH; McCullough LB; Sharp RR
    Acad Med; 2009 Apr; 84(4):495-7. PubMed ID: 19318788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioidentical hormone therapy: An assessment of provider knowledge.
    Files JA; Kransdorf LN; Ko M; Kling JM; David PS; Pruthi S; Sood R; Creedon D; Chang YH; Mayer AP
    Maturitas; 2016 Dec; 94():46-51. PubMed ID: 27823744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical ethics and ethical dilemmas.
    Iyalomhe GB
    Niger J Med; 2009; 18(1):8-16. PubMed ID: 19485140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ethical analysis of crisis in chronic pain care: facts, issues and problems in pain medicine; Part I.
    Giordano J; Schatman ME
    Pain Physician; 2008; 11(4):483-90. PubMed ID: 18690277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An author's guide to publication ethics: a review of emerging standards in biomedical journals.
    Roberts J
    Headache; 2009 Apr; 49(4):578-89. PubMed ID: 19338617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Hampshire critical access hospitals: CEOs' report on ethical challenges.
    Nelson W; Rosenberg MC; Weiss J; Goodrich M
    J Healthc Manag; 2009; 54(4):273-83; discussion 283-4. PubMed ID: 19681359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine.
    Gaffo AL; Saag KG
    Arthritis Res Ther; 2008; 10(5):120. PubMed ID: 18983690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to "The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?".
    Miller H
    Postgrad Med; 2009 Jul; 121(4):172. PubMed ID: 19641285
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of bioidentical hormones.
    Curcio JJ; Smolinski D; Dye J
    Menopause; 2005; 12(6):774-5; author reply 775. PubMed ID: 16278622
    [No Abstract]   [Full Text] [Related]  

  • 20. [Low-dose hormonal therapy during climacteric].
    Carranza Lira S
    Ginecol Obstet Mex; 2008 May; 76(5):267-74. PubMed ID: 18798431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.